ETFsBloomberg US Treasury 1-3 Year Index
Invesco
Invesco US Treasury Bond 1-3 Year UCITS ETF Dist
TRD3 XETRAIrelandNot PEA-eligible
Last close · EUR
34.23EUR
+0.15% · +€0.05
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
TRD3Base
- Fund charges
- 0.06%PRIIPs ongoing costs
- Fund size
- €1.4bnall share classes
- Return 1Y
- +5.2%
- Sharpe 3Y
- 0.02
- Volatility 1Y
- 5.3%annualised
- Holdings
- 96Fund holdings
Performance
Compare
- TRD3+5.2%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| TRD3 | +0.9% | +3.5% | +5.2% | +6.6% | +5.2% | +8.2% | +14.3% |
| MSCI World | -2.8% | -0.6% | +7.8% | +14.0% | +14.1% | +65.6% | +64.8% |
| Gap to MSCI World | +3.8% | +4.1% | -2.6% | -7.4% | -8.9% | -57.5% | -50.5% |
Risk and return
Sharpe ratio · 3Y
0.02
Below MSCI World · 1.24- Return p.a.
- +2.7%
- Volatility
- 6.3%
- Max loss
- -10.9%Jul 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
TRD3
0.02
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 14.4%
- Holdings
- 96
- As of
- 1US TSY N/B 3.5% 31/01/28US91282CGH882.15%
- 2US TSY N/B 4.5% 31/05/29US91282CKT701.40%
- 3US TSY N/B 4% 31/05/28US91282CQS341.37%
- 4US TSY N/B 4% 31/07/29US91282CLC371.37%
- 5US TSY N/B 4.25% 30/06/29US91282CKX821.36%
- 6US TSY N/B 4.625% 30/04/29US91282CKP581.36%
- 7US TSY N/B 4.125% 30/06/28US91282CQY021.35%
- 8US TSY N/B 4.125% 31/10/29US91282CLR061.35%
- 9US TSY N/B 4.25% 31/07/28US91282CRB991.35%
- 10US TSY N/B 4.75% 30/09/28US91282CRP851.35%
Countries
Not published · Country classification unavailable
Market cap
Weight vs holdings
14.4%of the fund sits in the top 10 holdings
14.4%47.3%38.1%
WeightHoldings
104046
- Holdings 1-10
- Holdings 11-50
- Holdings 51-96
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
